Some patients report that taking their injection at night allows them to sleep through the initial period when side effects might occur
The regulatory landscape has embraced ADCs, with approvals like Enhertu (trastuzumab deruxtecan) and Trodelvy (sacituzumab govitecan-hziy) marking them as vital therapies
48 h post-transfection, cells were pelleted and resuspended (~1.5 g packed volume) into 5 mL membrane preparation buffer followed by homogenisation with a polytron homogeniser at 4 C
Step 4: follow the standard tirzepatide titration schedule The standard tirzepatide titration increases the dose every four weeks: Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Weeks 17-20: 12.5mg weekly Weeks 21+: 15mg weekly (maximum dose) Not everyone needs to reach 15mg
GIT not only affects the metabolism of drugs, but also affects the absorption and transport due to the presence of multiple transporters (Shugarts and Benet, 2009)
Accessed 20 Apr 2017 Stanley CA, Bennett MJ, Longo N (2014) Plasma membrane carnitine transporter defect, In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G (eds) The online metabolic and molecular bases of inherited disease New York, McGraw-Hill, New York